Paion AG (PA8) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Paion AG (Paion) is a specialty pharmaceutical company that focuses on the development and commercialization of drugs to be used in -patient and hospital-based sedation, anesthesia and critical care services. The companys remimazolam is designed for the treatment of patients requiring sedation and anesthesia. It also develops morphine-6-glucuronide, a pharmacologically active metabolite of morphine which is used for the treatment of post-operative pain; and others. The company also conducts clinical development program for general anesthesia in Japan. It has a presence in the UK, the US and Germany. Paion is headquartered in Aachen, Germany.

Paion AG (PA8) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 5
List of Figures 5
Paion AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Paion AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Paion AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Paion AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Paion AG, Medical Devices Deals, 2012 to YTD 2018 10
Paion AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Paion AG, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Paion Raises US$4.8 Million In Venture Financing 12
Licensing Agreements 13
Mundipharma Enters into Licensing Agreement with Paion 13
Cosmo Pharma Enters into Licensing Agreement with Paion for Remimazolam 14
Paion Enters into Licensing Agreement with Yichang Humanwell for M6G 15
Paion Exercises Option for Licensing Agreement with PendoPharm for Remimazolam 16
Paion Extends Licensing Agreement with R-Pharm for Remimazolam for MENA Region 17
Paion Enters Into Licensing Agreement With R-Pharm For Remimazolam 18
Paion Extends Licensing Agreement With R-Pharm For Remimazolam 19
Paion Exercises Option for Licensing Agreement with Hana Pharma for Remimazolam 20
Yichang Humanwell Pharma Exercises Option with Paion to License Remimazolam 21
Equity Offering 23
Paion to Raise USD6 Million in Private Placement of Shares 23
Paion Raises USD9.2 Million in Private Placement of Shares 24
Paion to Raise USD5.3 Million in Rights Offering 25
Paion Raises USD10.9 Million in Private Placement of Shares 26
Paion Raises USD5.4 Million in Private Placement of Shares 27
Paion Raises USD61.3 Million in Rights Offering of Shares 28
Paion Raises USD1.4 Million in Private Placement of Shares 29
Paion Completes Private Placement of Shares for USD8.5 Million 30
Paion Completes Private Placement Of Shares For US$8.4 Million 31
Paion Completes Rights Offering of Shares for USD6.86 Million 32
Asset Transactions 33
Lundbeck Acquires Desmoteplase, Ischaemic Stroke Drug From Paion For US$27 Million 33
Paion AG - Key Competitors 35
Paion AG - Key Employees 36
Paion AG - Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Recent Developments 38
Financial Announcements 38
Mar 22, 2018: PAION reports on fiscal year and financial results 2017 38
Nov 08, 2017: Paion Publishes Group Quarterly Statement For The First Nine Months Of 2017 42
Aug 09, 2017: PAION reports financial results for the first half-year of 2017 45
Mar 16, 2017: PAION reports on fiscal year and financial results 2016 48
Product Approvals 51
Nov 14, 2017: FDA Considers Current Human Abuse Liability Program with Remimazolam in the U.S. As Sufficient; no Second Intranasal Study Required 51
Clinical Trials 52
Nov 23, 2017: PAION Announces Clinical Development Progress with Remimazolam by its Partner Hana Pharma in South Koera 52
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53

List Of Tables

List of Tables
Paion AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Paion AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Paion AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Paion AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Paion AG, Deals By Therapy Area, 2012 to YTD 2018 9
Paion AG, Medical Devices Deals, 2012 to YTD 2018 10
Paion AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Paion Raises US$4.8 Million In Venture Financing 12
Mundipharma Enters into Licensing Agreement with Paion 13
Cosmo Pharma Enters into Licensing Agreement with Paion for Remimazolam 14
Paion Enters into Licensing Agreement with Yichang Humanwell for M6G 15
Paion Exercises Option for Licensing Agreement with PendoPharm for Remimazolam 16
Paion Extends Licensing Agreement with R-Pharm for Remimazolam for MENA Region 17
Paion Enters Into Licensing Agreement With R-Pharm For Remimazolam 18
Paion Extends Licensing Agreement With R-Pharm For Remimazolam 19
Paion Exercises Option for Licensing Agreement with Hana Pharma for Remimazolam 20
Yichang Humanwell Pharma Exercises Option with Paion to License Remimazolam 21
Paion to Raise USD6 Million in Private Placement of Shares 23
Paion Raises USD9.2 Million in Private Placement of Shares 24
Paion to Raise USD5.3 Million in Rights Offering 25
Paion Raises USD10.9 Million in Private Placement of Shares 26
Paion Raises USD5.4 Million in Private Placement of Shares 27
Paion Raises USD61.3 Million in Rights Offering of Shares 28
Paion Raises USD1.4 Million in Private Placement of Shares 29
Paion Completes Private Placement of Shares for USD8.5 Million 30
Paion Completes Private Placement Of Shares For US$8.4 Million 31
Paion Completes Rights Offering of Shares for USD6.86 Million 32
Lundbeck Acquires Desmoteplase, Ischaemic Stroke Drug From Paion For US$27 Million 33
Paion AG, Key Competitors 35
Paion AG, Key Employees 36
Paion AG, Subsidiaries 37

List Of Figures

List of Figures
Paion AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Paion AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Paion AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Paion AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Paion AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Paion AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Paion AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Paion AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Paion AG, Medical Devices Deals, 2012 to YTD 2018 10

Paion AG (PA8) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Paion AG (Paion) is a specialty pharmaceutical company that focuses on the development and commercialization of drugs to be used in -patient and hospital-based sedation, anesthesia and critical care services.

USD 250 View Report

Paion AG Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Paion AG Company Profile is a detailed strategic and analytical report on Paion AG. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200 View Report

Paion AG Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Paion AG Company Profile is a detailed strategic and analytical report on Paion AG. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200 View Report

Paion AG (PA8) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Paion AG (Paion) is a specialty pharmaceutical company that focuses on the development and commercialization of drugs used for out-patient and hospital-based sedation, anesthesia and critical care services. The companys

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available